Home › Funds › AstraZeneca PLC ADRhedged
Fund family: Precidian ETFs Trust · Filed by Precidian ETFs Trust (CIK 1499655) · SEC series S000058696
Ticker: AZNH (C000192678)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 26 with, 0 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Precidian ETFs Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 13 | 0 |
| Capital Structure | 5 | 0 |
| Audit-related | 4 | 0 |
| Corporate Governance | 2 | 0 |
| Other Social Issues | 1 | 0 |
| Say-on-Pay | 1 | 0 |
26 ballot items at 3 meetings in 2025-2026. Download all votes (CSV)
In the 2025-2026 proxy season, AstraZeneca PLC ADRhedged (AZNH) voted at 3 shareholder meetings of 2 companies, on 26 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.